This grant application is for a second renewal of our group?s key NIH grant that supports development of optogenetic tools -- microbial opsins that enable safe, temporally precise, and high-magnitude control of neural activity in neurons in awake behaving mammals and other species of importance in neuroscience. Since our grant was first awarded in 2010, it has supported the development of optogenetic tools such as Arch (the first optogenetic neural silencer to result in ~100% optogenetic silencing of neural activity in awake behaving mice), ArchT (a 3x more light-sensitive relative of Arch), Chronos (an ultrafast optogenetic activator, used in contexts where speed is essential), Chrimson (the most redshifted optogenetic activator, useful for activation of large volumes of brain tissue as well as avoiding behavioral artifacts in Drosophila), Jaws (the most redshifted optogenetic silencer), SoCoChR (which enables single-cell, single-spike resolution optogenetics) and ChromeQ (a potassium- and sodium-selective optogenetic activator), resulting in 50 peer reviewed papers, and resulting in wide distribution of next-generation optogenetic tools throughout neuroscience. To date, we have primarily used genomic search to discover novel opsins, mining public and private databases to identify new candidates. Having screened through a large number of genomic resources to identify these molecules, however, one concern is that there are diminishing returns, and that some goals will not be met purely through genomic search, or even structure-guided site-directed mutagenesis. Directed evolution, which sifts through a large number of mutants of a parent gene to identify versions improved towards some goal, offers hope, but has not been applied to optogenetic tools due to the difficulty of performing directed evolution in mammalian cells (essential, since optogenetic tools that express well in cells commonly used in directed evolution, such as E. coli, do not express well in mammalian cells, and evolving optogenetic tools in such cells would likely de- optimize them for expression in mammalian cells), and the difficulty of performing multidimensional directed evolution (essential, because we need to optimize optogenetic tools towards multiple goals ? for example, localization, spectrum, and magnitude ? and optimizing too much along one axis will de-optimize the tool along other axes). We here propose to develop a directed evolution approach for optogenetic tool engineering (Aim 1), and apply it to several longstanding open needs in optogenetics: the creation of redshifted and blue spectrum-trimmed optogenetic activators, Aim 2; the creation of multiphoton-optimized silencers, Aim 3; and the optimization (by developing and applying automated patch clamp technology) of kinetics and ion selectivity, aiming to improve optogenetic tool kinetics for the aforementioned optogenetic tools as well as potassium conductances of light-gated potassium channels (Aim 4).
We aim to deliver to the neuroscience community a powerful toolbox of optogenetic controllers of widespread utility, and to disseminate them freely throughout the research world.

Public Health Relevance

The proposed research is relevant to public health because optogenetic tools for controlling the electrical activity of specific neuron types can reveal how they contribute to emergent brain functions, behaviors, and pathologies. Our tools will help scientists reveal many new clinical targets for treating brain disorders, pinpointing the sites in a circuit that, when targeted by a pharmacological agent or brain stimulator, lead to therapeutic benefit.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
2R01DA029639-09
Application #
9973808
Study Section
Bioengineering of Neuroscience, Vision and Low Vision Technologies Study Section (BNVT)
Program Officer
Berton, Olivier Roland
Project Start
2010-07-01
Project End
2024-01-31
Budget Start
2020-04-01
Budget End
2021-01-31
Support Year
9
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Massachusetts Institute of Technology
Department
Miscellaneous
Type
Other Specialized Schools
DUNS #
001425594
City
Cambridge
State
MA
Country
United States
Zip Code
02142
Piatkevich, Kiryl D; Jung, Erica E; Straub, Christoph et al. (2018) A robotic multidimensional directed evolution approach applied to fluorescent voltage reporters. Nat Chem Biol 14:352-360
Oran, Daniel; Rodriques, Samuel G; Gao, Ruixuan et al. (2018) 3D nanofabrication by volumetric deposition and controlled shrinkage of patterned scaffolds. Science 362:1281-1285
Kolb, Ilya; Talei Franzesi, Giovanni; Wang, Michael et al. (2018) Evidence for Long-Timescale Patterns of Synaptic Inputs in CA1 of Awake Behaving Mice. J Neurosci 38:1821-1834
Piatkevich, Kiryl D; Suk, Ho-Jun; Kodandaramaiah, Suhasa B et al. (2017) Near-Infrared Fluorescent Proteins Engineered from Bacterial Phytochromes in Neuroimaging. Biophys J 113:2299-2309
Freifeld, Limor; Odstrcil, Iris; Förster, Dominique et al. (2017) Expansion microscopy of zebrafish for neuroscience and developmental biology studies. Proc Natl Acad Sci U S A 114:E10799-E10808
Chang, Jae-Byum; Chen, Fei; Yoon, Young-Gyu et al. (2017) Iterative expansion microscopy. Nat Methods 14:593-599
Barykina, Natalia V; Subach, Oksana M; Piatkevich, Kiryl D et al. (2017) Green fluorescent genetically encoded calcium indicator based on calmodulin/M13-peptide from fungi. PLoS One 12:e0183757
Shemesh, Or A; Tanese, Dimitrii; Zampini, Valeria et al. (2017) Temporally precise single-cell-resolution optogenetics. Nat Neurosci 20:1796-1806
Berry, Shaun; Redmond, Shawn; Robinson, Paul et al. (2017) Fluidic microoptics with adjustable focusing and beam steering for single cell optogenetics. Opt Express 25:16825-16839
Galvan, Adriana; Stauffer, William R; Acker, Leah et al. (2017) Nonhuman Primate Optogenetics: Recent Advances and Future Directions. J Neurosci 37:10894-10903

Showing the most recent 10 out of 33 publications